Anti-Human HLA A2,B7 (MHC Class I) – Purified in vivo PLATINUM™ Functional Grade

Mouse IgG1 PLATINUM, Clone hksp OR Mouse IgG1 PLATINUM, Clone hksp84

Solubilized HLA-B7 antigen

This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.

Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.

Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Next Day 2-8°C

Clone BB7.6 recognizes an epitope shared by the human MHC class I molecule HLA-B.

HLA-B antibody, clone BB7.6, recognizes a shared epitope (Bw6) of the major histocompatibility complex (MHC) class I molecule human leukocyte antigen (HLA)-B¹. MHC class I is ubiquitously expressed on the cell surface of nucleated cells and consists of a 45-kDa type I transmembrane glycoprotein (α-chain or heavy chain) and a 12-kDa soluble protein (β2-microglobulin, β2M)^2,3. The α-chain consists of three domains (α1, α2, and α3)⁴. α1 and α2 form the closed antigen-binding groove and bind to 8-10 aa peptides derived from cytosolic antigens^5-7. β2M noncovalently associates with α3, which is essential for MHC stability. MHC class I plays a critical role in the adaptive immune response by presenting endogenous antigens to cytotoxic CD8 T cells. MHC class I molecules can also present exogenous antigens to CD8 T cells via a process known as cross-presentation⁸. The T cell receptor (TCR)/CD3 complex of CD8 T cells interacts with peptide-MHC class I, which induces CD8 T cell activation and subsequent cell-killing. CD8 molecules also bind to MHC class I, which helps augment TCR signaling⁹. In contrast to CD8 T cells, MHC class I is an inhibitory ligand for natural killer (NK) cells, promoting self tolerance¹⁰. MHC class I also contributes to the positive selection of CD8 T cells and NK cell specificity^11,12.

HLA-B is ubiquitously expressed on nucleated cells.

1. Lutz CT, et al. (1994) J Immunol. 153(9):4099-110.
2. Mitaksov V & Fremont DH. (2006) J Biol Chem. 281(15):10618-25.
3. Wieczorek M, et al. (2017) Front Immunol. 8:292.
4. Jones EY. (1997) Curr Opin Immunol. 9(1):75-9.
5. Matsumura M, et al (1992) Science. 257:927–34.10.1126/science.1323878
6. Bouvier M & Wiley DC. (1994) Science. 398–402.10.1126/science.8023162
7. Zacharias M & Springer S. (2004) Biophys J. 87:2203–14.10.1529/biophysj.104.044743
8. Cruz FM, et al. (2017) Annu Rev Immunol. 35:149-176.
9. Artyomov MN, et al. (2010) Proc Natl Acad Sci USA. 107(39):16916-16921.
10. Orr MT & Lanier LL. (2010) Cell. 142(6):847-856.
11. Raulet DH. (1994) Adv Immunol. 55:381-421.
12. Salcedo M & Ljunggren HG. (1996) Chem Immunol. 64:44-58.